Prognostic factors and treatment for advanced-stage borderline ovarian tumors;Facteurs pronostiques et traitements des tumeurs frontières de l'ovaire (TFO) de stade avancé

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 31, Issue 7, 2002, Pages 623-628

  Morice, P ^a   Camatte, S ^a   Rouzier, R ^a   Pautier, P ^a   Atallah, D ^a   Pomel, C ^a   Lhomme, C ^a   Duvillard, P ^a   Castaigne, D ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Borderline ovarian tumor; Conservative surgery; Invasive implants; Noninvasive implants; Peritoneal implants

Indexed keywords

ADVANCED CANCER; CANCER INCIDENCE; CHEMOSENSITIVITY; CONSERVATIVE TREATMENT; DISEASE ASSOCIATION; FEMALE FERTILITY; HISTOPATHOLOGY; HUMAN; MINIMAL RESIDUAL DISEASE; OVARY TUMOR; PERITONEUM; PROGNOSIS; REVIEW; SURGICAL APPROACH; TREATMENT INDICATION;

AFTERCARE; FEMALE; HUMANS; HYSTERECTOMY; INCIDENCE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OVARIAN NEOPLASMS; OVARIECTOMY; OVULATION INDUCTION; PERITONEAL NEOPLASMS; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0036859378     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Trope C, Kaern J, Vergote IB, Kristensen G, Abeler V. Are borderline tumors of the ovary overtreated both surgically and systemically? A review of four prospective randomized trials including 253 patients with borderline tumors. Gynecol Oncol 1993; 51: 236-43.
2. Duvillard P. Tumeurs ovariennes à la limite de la malignité. Ann Pathol 1996; 16: 396-405.
3. Bell DA, Weinstock RA, Scully R. Peritoneal implants of ovarian serous borderline tumors: Histologic features and prognosis. Cancer 1988; 62: 2212-22.
4. Gershenson D, Silva E, Levy L. Ovarian serous borderline tumors with invasive peritoneal implants. Cancer 1998; 82: 1096-103.
5. Gershenson D, Silva EL, Tortolero-Luna G. Serous borderline tumors of the ovary with non invasive peritoneal implants. Cancer 1998; 83: 2157-63.
6. Shiraki M, Otis C, Donovan J, Powell J. Case report: Ovarian serous borderline epithelial tumors with multiple retroperitoneal nodal involvement: Metastasis or malignant transformation of epithelial glandular inclusions? Gynecol Oncol 1992; 46: 255-8.
7. Gu J, Roth LM, Younger C, Michael H, Abdul-Karim FW, Zhang S, et al. Molecular evidence for the independent origin of extra-ovarian papillary serous tumors of low malignant potential. J Natl Cancer Inst 2001; 93: 1147-52.
8. Burks R, Sherman M, Kurman R. Micropapillary serous carcinoma of the ovary: A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol 1996; 20: 1319-30.
9. Kurman RJ, Trimble CL. The behavior of serous tumors of low malignant potential: Are they ever malignant? Int J Gynecol Pathol 1993; 12: 120-7.
10. Seidman J, Kurman R. Subclassification of serous borderline tumors of the ovary into begnin and malignant types: A clini-copathologic study of 65 advanced stage cases. Am J Surg Pathol 1996; 20: 1331-45.
11. Eichhorn J, Bell D, Young R, Scully R. Ovarian serous borderline tumors with micropapillary and cribriform patterns: A study of 40 cases and comparison with 44 cases without these patterns. Am J Surg Pathol 1999; 23: 397-409.
12. Bell D, Scully R. Ovarian serous borderline tumors with stromal micro-invasion: A report of 21 cases. Human Pathol 1990; 21: 397-403.
13. Bjorge T, Engeland A, Hansen S. Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954-1993. Int J Cancer 1997; 71: 780-6.
14. Kaern J, Trope C, Abeler V. A retrospective study of 370 borderline tumors of the ovary treated at the Norwegia Radium Hospital from 1970 to 1982. Cancer 1993; 71: 1810-20.
15. Trope C, Kaern J. Management of borderline tumors of the ovary: State of the art. Semin Oncol 1998; 25: 372-80.
16. Tamakoshi K, Kikkawa F, Nakashima N. Clinical behaviour of borderline ovarian tumors: A study of 150 cases. J Surg Oncol 1997; 64: 147-52.
17. Leake J, Currie J, Rosenshein N, Woodruff D. Long-term follow-up of serous ovarian tumors of low malignant potential. Gynecol Oncol 1992; 47: 150-8.
18. Morice P, Camatte S, Rey A, Lhommé C, Haie-Meder C, Duvillard P, et al. Prognostic factors of patients with advanced stage serous borderline tumor of the ovary. EJSO 2002; 28: 301-2.
19. Kennedy AW, Hart WR. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma. Cancer 1996; 78: 278-86.
20. Manchul LA, Simm J, Levin W. Borderline epithelial ovarian tumours: A review of 81 cases with an assessment of the impact of the treatment. Int J Rad Oncol Biol Phys 1992; 22: 867-74.
21. Robinson WR, Curtin JP, Morrow CP. Operative staging and conservative surgery in the management of low malignant potential ovarian tumors. Int J Gynecol Cancer 1992; 2: 113-8.
22. Michael H, Sutton G, Roth L. Ovarian carcinoma with extracellular mucin production: Reassessment of «pseudomyxoma ovarii et peritonei». Int J Gynecol Pathol 1987; 6: 298-310.
23. Darai E, Teboul J, Fauconnier A. Management and outcome of borderline ovarian tumors indicentally discovered at or after laparoscopy. Acta Obstet Gynecol Scand 1998; 77: 451-7.
24. Morice P, Camatte S, El Hassan J, Pautier P, Duvillard P, Castaigne D. Cinical outcomes and fertility results after conservative treatment for ovarian borderline tumor. Fertil Steril 2001; 75: 92-6.
25. Camatte, S, Morice P, Pautier P, Lhommé C, Duvillard P, Castaigne D. Fertility results after conservative treatment of advanced stage serous borderline tumors of the ovary. BJOG 2002; 100: 376-80.
26. Zanetta G, Rota S, Chiari S, Bonazzi C, Bratina G, Mangioni C. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: A prospective study. J Clin Oncol 2001; 19: 2658-64.
27. Leake JF, Ader JS, Woodruff JD. Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential. Gynecol Oncol 1991; 42: 124-30.
28. Lin P, Gershenson D, Bevers M. The current status of surgical staging of ovarian serous borderline tumors. Cancer 1999; 85: 905-11.
29. Camatte S, Morice P, Atallah D, Pautier P, Lhommé C, Haie-Meder C, et al. Lymph node disorders and prognostic involvement in patients treated for a borderline ovarian tumor: An analysis of a series of 42 lymphadenectomies. J Am Coll Surg, 2002; 125: 332-8.
30. Yazigi R, Sanddstad J, Munoy AK. Primary staging in ovarian tumors of low malignant potential. Gynecol Oncol 1988; 31: 402-8.
31. Prade M, Spatz A, Bentley R, Duvillard P, Bognel C, Robboy S. Borderline and malignant serous tumor arising in pelvic lymph nodes: Evidence of origin in benign glandular inclusions. Int J Gynecol Pathol 1995; 14: 87-91.
32. Tan LK, Flynn SD, Carcangiu ML. Ovarian serous borderline tumors with lymph node involvement: Clinicopathologic and DNA content study of seven cases and review of the litterature. Am J Surg Pathol 1994; 18: 904-12.
33. Young RC, Walton LA, Ellenberg S, Homesley HD, Wilbanks GD, Decker DG, et al. Adjuvant therapy in stage I and stage II epithelial ovarian cancer, results of two prospective randomized trials. New Engl J Med 1990; 322: 1021-7.
34. Beiner ME, Gotlieb WH, Davidson B, Kopolovic J, Ben-Baruch G. Infertility treatment after conservative management of borderline ovarian tumors. Cancer 2001; 92: 320-5.
35. Madelenat P, Meneux E, Fernandez H, Uzan S, Antoine JM. Place de l'assistance à la procréation après traitement conservateur d'une tumeur ovarienne: Enquête multicentrique française. X-Congrès de la Société Française d'Oncologie Gynécologique, Poitiers, 5-6 novembre 1999.